VRK1 and neoplasm: On the other way, inhibiting VRK1 role in DNA damage response to ionizing radiation or chemotherapy [21] can make tumor cells more sensitive to these treatments, and might consequently permit a reduction of toxic doses in new protocols based on combination therapies, once VRK1 inhibitors become available in the future.